JPMorgan Chase & Co’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.8K Buy
7,030
+5,979
+569% +$4.08K ﹤0.01% 5543
2025
Q1
$958 Sell
1,051
-11
-1% -$10 ﹤0.01% 5757
2024
Q4
$1.16K Buy
1,062
+158
+17% +$172 ﹤0.01% 5660
2024
Q3
$685 Hold
904
﹤0.01% 5701
2024
Q2
$1.12K Sell
904
-14,522
-94% -$18K ﹤0.01% 5581
2024
Q1
$29.2K Sell
15,426
-7,015
-31% -$13.3K ﹤0.01% 5143
2023
Q4
$59.2K Hold
22,441
﹤0.01% 4965
2023
Q3
$51.6K Sell
22,441
-5,140
-19% -$11.8K ﹤0.01% 4903
2023
Q2
$101K Buy
27,581
+27,542
+70,621% +$101K ﹤0.01% 4634
2023
Q1
$0 Hold
39
﹤0.01% 5845
2022
Q4
$0 Hold
39
﹤0.01% 5621
2022
Q3
$0 Hold
39
﹤0.01% 5559
2022
Q2
$0 Sell
39
-14,552
-100% ﹤0.01% 5628
2022
Q1
$71K Buy
14,591
+2,546
+21% +$12.4K ﹤0.01% 4878
2021
Q4
$136K Buy
12,045
+510
+4% +$5.76K ﹤0.01% 4707
2021
Q3
$168K Sell
11,535
-54
-0.5% -$786 ﹤0.01% 4493
2021
Q2
$135K Buy
11,589
+427
+4% +$4.97K ﹤0.01% 4666
2021
Q1
$136K Sell
11,162
-1,963
-15% -$23.9K ﹤0.01% 4582
2020
Q4
$165K Buy
13,125
+2,399
+22% +$30.2K ﹤0.01% 4198
2020
Q3
$165K Buy
10,726
+1,384
+15% +$21.3K ﹤0.01% 3821
2020
Q2
$229K Buy
9,342
+2,778
+42% +$68.1K ﹤0.01% 3617
2020
Q1
$93K Sell
6,564
-250
-4% -$3.54K ﹤0.01% 3962
2019
Q4
$108K Buy
6,814
+387
+6% +$6.13K ﹤0.01% 3997
2019
Q3
$54K Buy
6,427
+1,471
+30% +$12.4K ﹤0.01% 4223
2019
Q2
$38K Buy
4,956
+643
+15% +$4.93K ﹤0.01% 4360
2019
Q1
$33K Sell
4,313
-203
-4% -$1.55K ﹤0.01% 4358
2018
Q4
$21K Buy
4,516
+422
+10% +$1.96K ﹤0.01% 4487
2018
Q3
$37K Buy
4,094
+504
+14% +$4.56K ﹤0.01% 4446
2018
Q2
$43K Buy
3,590
+1,795
+100% +$21.5K ﹤0.01% 4359
2018
Q1
$25K Buy
+1,795
New +$25K ﹤0.01% 4351